# Verseon Corp: Form D filings

Verseon Corp, a pharmaceuticals company in Fremont, CA, filed 7 Form D notices with the SEC between 2015 and 2019. The latest, on April 24, 2019, reports $101,400 sold of a $101,400 offering to 1 investor.

Find out what Verseon Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Verseon%20Corp%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Verseon%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Fverseon-corp-1348948)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Verseon%20Corp%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Verseon%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Fverseon-corp-1348948)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 47071 Bayside Parkway, Fremont, CA, 94538
- Phone: (510) 225-9000
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1348948

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 24, 2019 | New notice | $101,400 | $101,400 | $0 | 1 | Mar 18, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1348948/000134894819000004/0001348948-19-000004-index.htm) |
| May 15, 2015 | New notice | $11,808,858 | $11,808,858 | $0 | 5 | Sep 16, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1348948/000134894815000009/0001348948-15-000009-index.htm) |
| May 15, 2015 | New notice | $451,000 | $451,000 | $0 | 10 | Nov 10, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1348948/000134894815000008/0001348948-15-000008-index.htm) |
| May 15, 2015 | New notice | $69,827 | $69,827 | $0 | 5 | Jun 30, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1348948/000134894815000007/0001348948-15-000007-index.htm) |
| May 15, 2015 | New notice | $259,573 | $259,573 | $0 | 13 | Sep 30, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1348948/000134894815000006/0001348948-15-000006-index.htm) |
| May 15, 2015 | New notice | $6,488,600 | $6,488,600 | $0 | 22 | Oct 31, 2005 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1348948/000134894815000005/0001348948-15-000005-index.htm) |
| May 14, 2015 | New notice | $5,832,264 | $5,832,264 | $0 | 28 | Feb 20, 2008 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1348948/000134894815000004/0001348948-15-000004-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Thomas Hecht | Director |  |
| Sangtae Kim | Director |  |
| Eniko Fodor | Executive Officer, Director |  |
| Adityo Prakash | Executive Officer, Director |  |
| David Kita | Executive Officer |  |

## Other pharmaceuticals companies in California that filed recently

- [Anvion Bio, Inc.](https://specstream.ai/data/form-d/company/anvion-bio-inc-2158000) $100,000 · Oct 7, 2026
- [Aqur Biosciences, Inc.](https://specstream.ai/data/form-d/company/aqur-biosciences-inc-2094075) $1.5 million · Sep 18, 2026
- [BTB Therapeutics, Inc.](https://specstream.ai/data/form-d/company/btb-therapeutics-inc-2055053) $8.9 million · Aug 12, 2026

[Every Form D from the week of Apr 22, 2019](https://specstream.ai/data/form-d/week/2019-04-22) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Verseon Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).